Aardvark Therapeutics, Inc.
AARDNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $84.33M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.35$16.60
- Volume (live)
- -
- Avg. volume (3M)
- 127.78K
Aardvark Therapeutics (AARD) Stock Price & Financial Analysis
Aardvark Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.73 - $4.19 |
|---|---|
| 52-Week High | $16.60 |
| 52-Week Low | $3.35 |
| Open | $4.19 |
| Volume (last close) | 97.16K |
| Average Volume (3M) | 127.78K |
| 50-Day MA | $5.79 |
|---|---|
| 200-Day MA | $7.00 |
| 1-Year Change | −69.87% |
| Market Cap | 84.33M |
|---|---|
| Shares Outstanding | 21.85M |
| Price to Book (P/B) | 1.13 |
| EV/EBITDA | -0.15 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Aardvark Therapeutics at a Glance
As of the Oct 16, 2026 close, Aardvark Therapeutics (AARD) has a market capitalization of $84.33M.
As of its latest reported balance sheet, it holds $73.85M in cash and securities against $677.00K of debt, a net cash position of $73.17M.
Aardvark Therapeutics does not currently pay a dividend.
The share price is down 69.9% over the past year. At $3.80 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $3.35 to $16.60, below its 200-day moving average of $7.00.
Based on 7 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $5.25, 38.2% above the Oct 16, 2026 close.
Frequently Asked Questions About Aardvark Therapeutics
What is the current stock price for AARD?
As of the Oct 16, 2026 close, AARD stock trades at $3.80. The 52-week range is $3.35–$16.60, with a day range of $3.73–$4.19.
What is the P/E ratio for AARD?
The P/E ratio (Price-to-Earnings) for AARD is shown in the Key Statistics section. This valuation metric helps compare Aardvark Therapeutics, Inc. to industry peers.
Does AARD pay dividends?
Aardvark Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for AARD?
Based on ratings from 7 professional analysts over the last 90 days, the consensus for AARD is Hold. The average 12-month price target is $5.25, a 38.2% upside from the Oct 16, 2026 close of $3.80.
What is the market cap of AARD?
As of the Oct 16, 2026 close, Aardvark Therapeutics's market capitalization is $83.0M, classifying it as a micro-cap company. Aardvark Therapeutics operates in the Healthcare sector within the Biotechnology industry.